Incyte - 49 Year Dividend History | INCY
Historical dividend payout and yield for Incyte (INCY) since 1971. The current TTM dividend payout for Incyte (INCY) as of February 21, 2020 is $0.00. The current dividend yield for Incyte as of February 21, 2020 is 0.00%.
||Medical - Biomedical and Genetics
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. They have a diverse and growing portfolio of product candidates, including both small and large molecules.